Please login to the form below

Not currently logged in
Email:
Password:

Prostrakan and Bayer Schering enter testosterone partnership

UK speciality pharmaceutical company ProStrakan has announced that it has granted Bayer Schering an exclusive license to develop and commercialise its testosterone gel

UK speciality pharmaceutical company ProStrakan has announced that it has granted Bayer Schering an exclusive license to develop and commercialise its testosterone gel, Tostran in 65 countries worldwide.

Tostran is a testosterone gel indicated for testosterone replacement therapy in men with hypogonadism, a condition where the testes fail to produce androgen and/or sperm.

Under the terms of the agreement, Bayer Schering will make an undisclosed upfront payment to ProStraken, which will be followed by milestone payments subject to certain approvals and sales targets being met.

Dr Wilson Totten, ProStrakan's chief executive, said: “Outlicensing Tostran to Bayer Schering Pharma in these territories is in line with our strategy of capitalising on the value of our products in parts of the world that are non-core for ProStrakan. In Bayer Schering Pharma, we have a worthy and sizeable partner with a deep understanding of the testosterone replacement market who is well-placed to bring this product to clinicians in each of these territories.”

Tostran is currently marketed in Europe under several brand names including Tostran, Tostrex and Itnogen. The product will be branded Fortigel in the US.

27th November 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics